The two long-term drivers for weight loss and control are your basal metabolic rate, the number of calories you burn while your carcass is at rest, and your muscle tissue’s ability to perform and sustain physical activity for extended periods moving your carcass. Both are dependent on the amount of muscle tissue you have developed through conditioning or granted through genetics. So, before you decide to withdraw from your 401K to pay for your hit of Wegovy or Ozempic or any other miraculously pitched expensive weight loss drug, you need to consider some basic physiology.
Ozempic, a drug indicated for Type II diabetes, has become the latest weight-loss darling. Not since ivermectin has a drug gained so much interest from its off-label uses. Let’s take a deeper look at the science and a regulatory conundrum.